Ignite Creation Date:
2024-05-06 @ 7:37 AM
Last Modification Date:
2024-10-26 @ 11:50 AM
Study NCT ID:
NCT02564536
Status:
WITHDRAWN
Last Update Posted:
2017-05-08
First Post:
2015-09-29
Brief Title:
Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm MPNMyelodysplastic Syndrome MDS
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2015-09-29
First Submit QC Date:
September 29 2015
Study First Post Date:
2015-09-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-03
Last Update Post Date:
2017-05-08
Last Update Post Date Type:
ACTUAL